Scientists Question Data Behind an Experimental Alzheimers Drug
Charles Spruck, a cancer researcher at the Sanford Burnham Prebys Medical Discovery Institute in San …
Charles Spruck, a cancer researcher at the Sanford Burnham Prebys Medical Discovery Institute in San …
Biogen said on Tuesday that it will replace its chief executive and effectively give up …
A closely watched clinical trial of a potential Alzheimer’s drug failed to prevent or slow …
Researchers identified a protein in the fluid that could boost the cognition of aging animals and might lead to future treatments for people.
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
With the arrival of amyloid PET– which includes infusing patients with “tracer” molecules that adhere …
Middle age is associated with typical changes in cognitive abilities. When we experience these normal …
One in five deaths globally is linked to this. After analyzing information gathered from data …